Oct 1, 1974

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

Transplantation
H GlucksbergE D Thomas

Abstract

No abstract listed.

  • References
  • Citations2170

References

  • We're still populating references for this paper, please check back later.

Mentioned in this Paper

Cholera Infantum
Graft-vs-Host Disease
Graft Vs Host Reaction
HLA Antigens
Therapeutic Immunosuppression
Tissue Donors
HLA Typing
Hypoplastic Anemia
Transplantation, Homologous
Bone Marrow Cell Transplantation

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.